Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Calmy

Showing results (21-30 of 59) with videos related to

Pageof 6
Sort By:
HIV Medicine|April 28, 2007
Combination antiretroviral therapy without a nucleoside reverse transcriptase inhibitor: experience from 334 patients in three cohortsA Calmy, K Petoumenos, C Lewden, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|November 10, 2012
Long-term HIV infection and antiretroviral therapy are associated with bone microstructure alterations in premenopausal womenA Calmy, T Chevalley, C Delhumeau, et al.
HIV Medicine|October 21, 2014
Gender inequalities in the response to combination antiretroviral therapy over time: the Swiss HIV Cohort StudyC Rosin, L Elzi, C Thurnheer, et al.
Tropical Medicine & International Health : TM & IH|June 21, 2014
Management of BU-HIV co-infectionD P O'Brien, N Ford, M Vitoria, et al.
New Microbes and New Infections|June 18, 2015
Dolutegravir-based antiretroviral therapy in a severely overweight child with a multidrug-resistant human immunodeficiency virus infection. A case report and reviewN Wagner, C A Wyler-Lazarevic, S Yerly, et al.
New Microbes and New Infections|June 4, 2016
Corrigendum to "Dolutegravir-based antiretroviral therapy in a severely overweight child with a multi-drug resistant human immunodeficiency virus infection. A case report and review" [New Microbes New Infect] 6 (2015) 1-4]N Wagner, C A Wyler-Lazarevic, S Yerly, et al.
HIV Medicine|May 10, 2014
Predicting smoking cessation and its relapse in HIV-infected patients: the Swiss HIV Cohort StudyJ Schäfer, J Young, E Bernasconi, et al.
HIV Medicine|March 19, 2010
No significant effect of uridine or pravastatin treatment for HIV lipoatrophy in men who have ceased thymidine analogue nucleoside reverse transcriptase inhibitor therapy: a randomized trialA Calmy, M Bloch, H Wand, et al.
HIV Medicine|November 19, 2011
Strong serological responses and HIV RNA increase following AS03-adjuvanted pandemic immunization in HIV-infected patientsA Calmy, M Bel, A Nguyen, et al.
HIV Medicine|April 21, 2021
Changes in alanine aminotransferase levels after switching from tenofovir disoproxil fumarate (TDF) to tenofovir alafenamide (TAF) in HIV-positive people without viral hepatitis in the Swiss HIV Cohort StudyH Kovari, B Surial, P E Tarr, et al.
Pageof 6

Showing results (21-30 of 59) with videos related to

Sort By:
Pageof 6
HIV Medicine|April 28, 2007
Combination antiretroviral therapy without a nucleoside reverse transcriptase inhibitor: experience from 334 patients in three cohortsA Calmy, K Petoumenos, C Lewden, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|November 10, 2012
Long-term HIV infection and antiretroviral therapy are associated with bone microstructure alterations in premenopausal womenA Calmy, T Chevalley, C Delhumeau, et al.
HIV Medicine|October 21, 2014
Gender inequalities in the response to combination antiretroviral therapy over time: the Swiss HIV Cohort StudyC Rosin, L Elzi, C Thurnheer, et al.
Tropical Medicine & International Health : TM & IH|June 21, 2014
Management of BU-HIV co-infectionD P O'Brien, N Ford, M Vitoria, et al.
New Microbes and New Infections|June 18, 2015
Dolutegravir-based antiretroviral therapy in a severely overweight child with a multidrug-resistant human immunodeficiency virus infection. A case report and reviewN Wagner, C A Wyler-Lazarevic, S Yerly, et al.
New Microbes and New Infections|June 4, 2016
Corrigendum to "Dolutegravir-based antiretroviral therapy in a severely overweight child with a multi-drug resistant human immunodeficiency virus infection. A case report and review" [New Microbes New Infect] 6 (2015) 1-4]N Wagner, C A Wyler-Lazarevic, S Yerly, et al.
HIV Medicine|May 10, 2014
Predicting smoking cessation and its relapse in HIV-infected patients: the Swiss HIV Cohort StudyJ Schäfer, J Young, E Bernasconi, et al.
HIV Medicine|March 19, 2010
No significant effect of uridine or pravastatin treatment for HIV lipoatrophy in men who have ceased thymidine analogue nucleoside reverse transcriptase inhibitor therapy: a randomized trialA Calmy, M Bloch, H Wand, et al.
HIV Medicine|November 19, 2011
Strong serological responses and HIV RNA increase following AS03-adjuvanted pandemic immunization in HIV-infected patientsA Calmy, M Bel, A Nguyen, et al.
HIV Medicine|April 21, 2021
Changes in alanine aminotransferase levels after switching from tenofovir disoproxil fumarate (TDF) to tenofovir alafenamide (TAF) in HIV-positive people without viral hepatitis in the Swiss HIV Cohort StudyH Kovari, B Surial, P E Tarr, et al.
Pageof 6